●  MARSH & MCLENNAN COMPANIES, INC. · FY 2022 

Market Risk

Global market fluctuations present quantifiable financial exposures for Marsh & McLennan Companies, Inc., with estimates showing that shifts in major exchange rates could impact net operating income by approximately \$74 million. Furthermore, changes in short-term interest rates are calculated to increase or decrease annual interest income by around \$30 million based on current balances. These quantitative assessments highlight the sensitivity of the company's finances to volatility across foreign currency and debt markets.

MRSH L1 Synthesis
●  SYMBOLOGY.ONLINE l1 SYNTHESIS 

Marsh & Mclennan Companies, Inc Market Risk Synthesis

Quantitative Market Risk Exposure Assessment

This assessment synthesizes the market risk disclosures from MARSH & MCLENNAN COMPANIES, INC.'s 2022 10-K filing, focusing on quantitative exposure and mitigation strategies across key financial risks.

Interest Rate Sensitivity

The Company is exposed to interest rate changes primarily through its cash and fiduciary cash investments.

Magnitude of Exposure and Impact
  • Exposure: The company holds significant balances in cash and cash equivalents ($1,442 million in 2022) and cash held in a fiduciary capacity ($10,660 million in 2022), both subject to variable interest rates.
  • Quantitative Impact (Stress Test): Based on the December 31, 2022 balances, a change in short-term interest rates of $\pm 10%$ or $25$ basis points for 2023 is estimated to increase or decrease annual interest income by approximately $30 million.
  • Trend: The risk increased from the prior year; at December 31, 2021, a similar change would have impacted interest income by only $\pm $1$ million. This change is attributed to higher short-term interest rates compared to 2021.
Mitigation Strategies
  • Strengths: The Company employs an approved investment policy that mandates the preservation of principal and liquidity. Investments are primarily held in short-term bank deposits and liquid money market funds, which generally manage duration risk effectively. Diversification is required with counter-party limits assigned based on credit rating.
  • Weaknesses: No specific hedging instruments (e.g., interest rate swaps) were disclosed to directly mitigate the impact of rising rates on the overall portfolio value; mitigation relies heavily on investment policy and liquidity management.

Foreign Currency Exposure

The Company faces translation risk from international operations, with non-U.S. based revenue constituting approximately 51% of total revenue.

Magnitude of Exposure and Impact
  • Exposure: The company has exposure to approximately 80 foreign currencies. Key major currencies identified include the Euro, Sterling, Australian dollar, and Canadian dollar.
  • Quantitative Impact (Stress Test): If the exchange rates of these major currencies moved $10%$ in the same direction against the U.S. dollar compared to 2022, net operating income is estimated to increase or decrease by approximately $74 million. This represents an increase from the $\pm $57$ million estimate for 2021.
  • Mitigation Effectiveness: The Company notes that in most cases, foreign currency revenue and expenses are denominated in the functional currency of the foreign location, which generally mitigates the impact on net operating income under normal circumstances.
Mitigation Strategies
  • Strengths: The Company actively uses forward contracts and options to limit foreign currency exchange rate exposure for specific, clearly defined transactions arising in the ordinary course of business. The natural offset between foreign revenue and expenses also provides a degree of inherent risk mitigation.
  • Weaknesses: Despite these measures, the filing acknowledges that external market factors or macroeconomic events can cause periods where the impact is not mitigated, suggesting potential limitations to current hedging effectiveness during extreme volatility.

Equity Price Risk

The Company holds diverse investments across public companies, private companies, and private equity funds.

Magnitude of Exposure and Impact
  • Exposure Breakdown: The investment portfolio includes:
    • $\sim $17$ million valued using readily determinable fair values.
    • $\sim $42$ million without readily determinable fair values.
    • $\sim $215$ million accounted for using the equity method.
  • Risk: The primary risk is a decline in market value, which could result in realized impairment losses if deemed non-temporary.
Mitigation Strategies
  • Strengths: The Company maintains periodic reviews of the carrying value of these investments to ensure appropriate valuation adjustments are made under applicable accounting pronouncements.
  • Weaknesses: No specific quantitative risk management tools (e.g., portfolio hedging, diversification metrics beyond general investment policy) were disclosed regarding the $\sim $215$ million equity method investments or the non-readily determinable assets, leaving the Company reliant on periodic valuation reviews to manage impairment risk.

Commodity Price Risk

No specific exposure to commodity price fluctuations was identified or disclosed in this section of the filing.

Quantitative Measures and Stress Testing

The Company utilizes quantitative stress testing for interest rate and foreign currency risks.

Assessment
  • Strengths: The disclosure provides clear, quantifiable estimates (e.g., $\pm $30$ million for interest rates; $\pm $74$ million for FX) based on defined market movements ($10%$ or $25$ basis points), allowing stakeholders to gauge the potential financial impact of adverse scenarios.
  • Weaknesses: Value-at-Risk (VaR) metrics, sensitivity tables beyond the specific interest rate and FX tests provided, or detailed stress test results for equity risk were not disclosed in this excerpt.